Sterling Capital Management LLC Apellis Pharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $7.3 Trillion
- Q4 2024
A detailed history of Sterling Capital Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 1,687 shares of APLS stock, worth $41,179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,687
Previous 1,898
11.12%
Holding current value
$41,179
Previous $54.7 Million
1.66%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$298 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$290 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$288 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$245 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$235 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.68B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...